thalidomide has been researched along with Acne in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez-Velázquez, A | 1 |
| Falkenhain-López, D | 1 |
| Arroyo-Andrés, J | 1 |
| Montero-Menárguez, J | 1 |
| García-Donoso, C | 1 |
| Postigo-Llorente, C | 1 |
| Yazici, H | 1 |
| Fresko, I | 1 |
| Hamuryudan, V | 1 |
| Mat, C | 1 |
| Melikoglu, M | 1 |
| Ozyazgan, Y | 1 |
| Tuzun, Y | 1 |
| Yurdakul, S | 1 |
1 review available for thalidomide and Acne
| Article | Year |
|---|---|
Behçet's syndrome. The Cerrahpasa experience. Members of the Behçet's Syndrome Research Centre.
Topics: Acne Vulgaris; Azathioprine; Behcet Syndrome; Clinical Trials as Topic; Humans; Immunosuppressive Ag | 1999 |
1 trial available for thalidomide and Acne
| Article | Year |
|---|---|
Behçet's syndrome. The Cerrahpasa experience. Members of the Behçet's Syndrome Research Centre.
Topics: Acne Vulgaris; Azathioprine; Behcet Syndrome; Clinical Trials as Topic; Humans; Immunosuppressive Ag | 1999 |
1 other study available for thalidomide and Acne
| Article | Year |
|---|---|
Apremilast: A novel adjuvant treatment for refractory isotretinoin-induced acne fulminans.
Topics: Acne Vulgaris; Adjuvants, Immunologic; Humans; Isotretinoin; Thalidomide | 2022 |